{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:39:12Z","timestamp":1787611152475,"version":"build-2736575974"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18H02337"],"award-info":[{"award-number":["18H02337"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18F18399"],"award-info":[{"award-number":["18F18399"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Human babesiosis caused by Babesia microti can be fatal in immunocompromised patients, and the currently used drugs are often ineffective. A recent study found that clofazimine clears B. microti Munich strain in immunocompromised mice. In the present study, we investigated the efficacies of clofazimine and 2-drug combinations involving clofazimine, atovaquone, and azithromycin against B. microti Peabody mjr strain in immunocompromised mice. Treatment with clofazimine alone, clofazimine plus azithromycin, and atovaquone plus azithromycin was ineffective and failed to eliminate the parasites completely, while a 44-day treatment with clofazimine plus atovaquone was highly effective and resulted in a radical cure.<\/jats:p>","DOI":"10.1093\/infdis\/jiab537","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T18:20:07Z","timestamp":1634581207000},"page":"238-242","source":"Crossref","is-referenced-by-count":16,"title":["Combination of Clofazimine and Atovaquone as a Potent Therapeutic Regimen for the Radical Cure of <i>Babesia microti<\/i> Infection in Immunocompromised Hosts"],"prefix":"10.1093","volume":"225","author":[{"given":"Bumduuren","family":"Tuvshintulga","sequence":"first","affiliation":[{"name":"National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thillaiampalam","family":"Sivakumar","sequence":"additional","affiliation":[{"name":"National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arifin Budiman","family":"Nugraha","sequence":"additional","affiliation":[{"name":"National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Believe","family":"Ahedor","sequence":"additional","affiliation":[{"name":"National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enkhbaatar","family":"Batmagnai","sequence":"additional","affiliation":[{"name":"National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davaajav","family":"Otgonsuren","sequence":"additional","affiliation":[{"name":"National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MingMing","family":"Liu","sequence":"additional","affiliation":[{"name":"National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuenan","family":"Xuan","sequence":"additional","affiliation":[{"name":"National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Igarashi","sequence":"additional","affiliation":[{"name":"National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoaki","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"key":"2022011805202004600_CIT0001","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMra1202018","article-title":"Human babesiosis.","volume":"366","author":"Vannier","year":"2012","journal-title":"N Engl J Med"},{"key":"2022011805202004600_CIT0002","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/525852","article-title":"Persistent and relapsing babesiosis in immunocompromised patients.","volume":"46","author":"Krause","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2022011805202004600_CIT0003","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/649859","article-title":"Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.","volume":"50","author":"Wormser","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2022011805202004600_CIT0004","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/cid\/cix477","article-title":"Clinical and molecular evidence of atovaquone and azithromycin resistance in relapsed Babesia microti infection associated with rituximab and chronic lymphocytic leukemia.","volume":"65","author":"Simon","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2022011805202004600_CIT0005","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.20151519","article-title":"Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone.","volume":"213","author":"Lawres","year":"2016","journal-title":"J Exp Med"},{"key":"2022011805202004600_CIT0006","doi-asserted-by":"crossref","first-page":"16079","DOI":"10.1038\/nmicrobiol.2016.79","article-title":"A global map of genetic diversity in Babesia microti reveals strong population structure and identifies variants associated with clinical relapse.","volume":"1","author":"Lemieux","year":"2016","journal-title":"Nat Microbiol"},{"key":"2022011805202004600_CIT0007","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1128\/AAC.06396-11","article-title":"High risk of QT interval prolongation and torsades de pointes associated with intravenous quinidine used for treatment of resistant malaria or babesiosis.","volume":"56","author":"Wroblewski","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2022011805202004600_CIT0008","doi-asserted-by":"crossref","first-page":"105822","DOI":"10.1016\/j.ijantimicag.2019.10.003","article-title":"World Health Organization 2018 treatment guidelines for rifampicin-resistant tuberculosis: uncertainty, potential risks and the way forward.","volume":"55","author":"Deun","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"2022011805202004600_CIT0009","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jac\/dki470","article-title":"Identification of new antimalarial drugs by linear discriminant analysis and topological virtual screening.","volume":"57","author":"Mahmoudi","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"2022011805202004600_CIT0010","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ja.2010.72","article-title":"In vitro and in vivo anti-Trypanosoma brucei activities of phenazinomycin and related compounds.","volume":"63","author":"Otoguro","year":"2010","journal-title":"J Antibiot (Tokyo)"},{"key":"2022011805202004600_CIT0011","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1128\/AAC.01614-15","article-title":"Clofazimine inhibits the growth of Babesia and Theileria parasites in vitro and in vivo.","volume":"60","author":"Tuvshintulga","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2022011805202004600_CIT0012","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/infdis\/jiaa195","article-title":"Clofazimine, a promising drug for the treatment of Babesia microti infection in severely immunocompromised hosts.","volume":"222","author":"Tuvshintulga","year":"2020","journal-title":"J Infect Dis"},{"key":"2022011805202004600_CIT0013","doi-asserted-by":"crossref","first-page":"ofaa183","DOI":"10.1093\/ofid\/ofaa183","article-title":"Novel administration of clofazimine for the treatment of Mycobacterium avium infection.","volume":"7","author":"Valinetz","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2022011805202004600_CIT0014","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1054\/drup.2000.0157","article-title":"Atovaquone resistance in malaria parasites.","volume":"3","author":"Vaidya","year":"2000","journal-title":"Drug Resist Updat"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiab537\/41319819\/jiab537.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/225\/2\/238\/42224205\/jiab537.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/225\/2\/238\/42224205\/jiab537.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T05:20:41Z","timestamp":1642483241000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/225\/2\/238\/6401716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":14,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,11,17]]},"published-print":{"date-parts":[[2022,1,18]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiab537","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,15]]},"published":{"date-parts":[[2021,11,17]]}}}